Open Access

Neuropathic Nav1.3-mediated sensitization to P2X activation is regulated by protein kinase C

  • Gary Mo1, 2,
  • Rebecca Grant2,
  • Dajan O'Donnell2,
  • David S Ragsdale1,
  • Chang-Qing Cao2 and
  • Philippe Séguéla1Email author
Molecular Pain20117:14

https://doi.org/10.1186/1744-8069-7-14

Received: 7 November 2010

Accepted: 11 February 2011

Published: 11 February 2011

Abstract

Background

Increased neuronal excitability and spontaneous firing are hallmark characteristics of injured sensory neurons. Changes in expression of various voltage-gated Na+ channels (VGSCs) have been observed under neuropathic conditions and there is evidence for the involvement of protein kinase C (PKC) in sensory hyperexcitability. Here we demonstrate the contribution of PKC to P2X-evoked VGSC activation in dorsal root ganglion (DRG) neurons in neuropathic conditions.

Results

Using the spinal nerve ligation (SNL) model of neuropathic pain and whole-cell patch clamp recordings of dissociated DRG neurons, we examined changes in excitability of sensory neurons after nerve injury and observed that P2X3 purinoceptor-mediated currents induced by α,β-meATP triggered activation of TTX-sensitive VGSCs in neuropathic nociceptors only. Treatment of neuropathic DRGs with the PKC blocker staurosporine or calphostin C decreased the α,β-meATP-induced Na+ channels activity and reversed neuronal hypersensitivity. In current clamp mode, α,β-meATP was able to evoke action-potentials more frequently in neuropathic neurons than in controls. Pretreatment with calphostin C significantly decreased the proportion of sensitized neurons that generated action potentials in response to α,β-meATP. Recordings measuring VGSC activity in neuropathic neurons show significant change in amplitude and voltage dependence of sodium currents. In situ hybridization data indicate a dramatic increase in expression of embryonic Nav1.3 channels in neuropathic DRG neurons. In a CHO cell line stably expressing the Nav1.3 subunit, PKC inhibition caused both a significant shift in voltage-dependence of the channel in the depolarizing direction and a decrease in current amplitude.

Conclusion

Neuropathic injury causes primary sensory neurons to become hyperexcitable to ATP-evoked P2X receptor-mediated depolarization, a phenotypic switch sensitive to PKC modulation and mediated by increased activity of TTX-sensitive VGSCs. Upregulation in VGSC activity after injury is likely mediated by increased expression of the Nav1.3 subunit, and the function of the Nav1.3 channel is regulated by PKC.

Background

Neuronal hypersensitivity is a hallmark feature of neuropathic pain. The ATP-gated ionotropic P2X3 receptor [1, 2] has been demonstrated to play significant roles in neuronal hyperexcitability and neuropathic pain in damaged sensory neurons [36]. To date, however, there is no clear understanding of how the P2X3 receptor influences neuronal hypersensitivity under neuropathic pain conditions. If the P2X3 receptor contributes directly to neuronal hypersensitivity, one might expect an upregulation of its function after nerve damage. Consistent with this hypothesis, some studies have described increased P2X3 expression following nerve injury [7, 8]. However, others have reported evidence of decreased P2X3 expression in neuropathic conditions [9] with lowered or unchanged level of P2X receptor function in subsets of dorsal root ganglion (DRG) neurons [10]. Indeed, while ATP evokes strong responses from neuropathic sensory neurons, it is not clear whether this is a direct effect of increased P2X3 currents, or an indirect effect reflecting increased intrinsic neuronal excitability.

Numerous reports have demonstrated an association between neuropathic injuries and changes in the expression of voltage-gated sodium channels (VGSC) [11]. One of the most dramatic VGSC alterations after neuropathic injury is the upregulation of the embryonic Nav1.3 α subunit [12]. The Nav1.3 α subunit is highly expressed in embryonic DRG neurons, but is developmentally regulated such that it is only weakly expressed in adult DRG neurons [13]. Regulation of gene expression is not the only mechanism known to modulate VGSC function in neurons. Changes in phosphorylation states mediated by serine/threonine protein kinases have been shown to directly affect functional properties of Nav1.2 [14], Nav1.7 and Nav1.8 [15, 16]. Involvement of serine/threonine protein kinases, especially protein kinase C (PKC), in neuropathic pain has been clearly demonstrated [17, 18]. However, a modulatory role of PKC on the Nav1.3 subunit has yet to be determined.

The aim of the present study is to understand how P2X3 receptors and Nav1.3 VGSCs contribute to neuronal hyperexcitability in neuropathic DRG neurons. Here we report that upregulation of Nav1.3 increases intrinsic neuronal excitability, whereas ATP-gated currents through P2X3 receptors contribute sufficient depolarization to elicit spikes in damaged DRG neurons. We also show that PKC modulates neuronal hyperexcitability by regulating the function of Nav1.3. These data provide new insights into how injured peripheral nociceptors mediate abnormal ectopic firing that could sustain neuropathic pain.

Materials and methods

Neuropathic model

This study was conducted under a protocol that has been approved by an ethical committee. The animals were kept and experiments were performed at AstraZeneca R&D Montréal which has accreditation from CCAC (Canadian Council on Animal Care), AAALAC (Association for the Assessment and Accreditation of Laboratory Animal Care) and/or approved by AZ GVC (AstraZeneca Global Veterinary Council) for study conduct.

Spinal nerve ligations (SNL) at L5 and L6 levels were carried out in Sprague-Dawley male rats weighing 125-150 g following a protocol previously described by Kim and Chung [19]. In summary, after inducing deep anaesthesia using isoflurane inhalation, a 2 cm dorsal incision was made approximately from L3 and S2 vertebral regions. Paraspinal muscles on the left side were detached from the spinous processes in order to reveal the L5 and L6 spinal nerves. Once the nerves were cleared from connective tissue, a tight ligation was made on each nerve using a 4-0 silk thread. The muscles were then moved back to the appropriate regions along the vertebrae then the incision was sutured and antibiotic ointment was applied. During surgery the animals were given a constant flow of isoflurane inhalation to maintain deep anaesthesia.

Neuronal and non-neuronal cell culture

DRGs from lumbar segments L4-L6 were extracted from naïve male Sprague-Dawley rats weighing 340-400 g (Charles River Canada) under deep anaesthesia induced by isoflurane.

For the SNL conditions, L5 and L6 lumbar segment DRGs on the ipsilateral side of the ligation were harvested at 35-40 days post-injury under deep anaesthesia induced by isoflurane.

Extracted DRGs were placed in ice-cold oxygenated DMEM (Gibco) for removal of connective tissue and dura mater. The isolated DRGs were then placed into DMEM containing 1 mg/mL of papain and 2 mg/mL collagenase type II (Sigma-Aldrich) and incubated for 1 h at 37°C and 100% humidity. After enzymatic digestion, the DRGs were transferred into DMEM containing 10% FBS and 1% L-glutamine, dissociated into single neurons by means of trituration using fire-polished pipettes. Dissociated neurons were then plated onto 35 mm cell culture dishes (Sarstedt) coated with laminin (BD Bioscience) and poly-D-lysine (Sigma-Aldrich), and cultured for 48 h at 37°C and 100% humidity in F-12 media (Gibco) containing 10% FBS, 1% L-glutamine as well as 100 U/mL penicillin and streptomycin.

CHO cells stably expressing human Nav1.3 α subunit (cell line CNahIII-12, [20]) were cultured in IMDM supplemented with 10% fetal bovine serum, 1% sodium hypoxanthine and thymidine (HT) supplement, 1% MEM non-essential amino acids, 100 U/mL Penicillin and streptomycin, and 400 μg/mL G418 (Gibco).

Patch-clamp recordings in DRG neurons and CHO cells

Whole-cell patch-clamp recordings on DRG neurons were conducted using micropipettes produced by pulling borosilicate glass tubes using a P-97 puller (Sutter Instrument, Novato, CA), and fire-polishing with a MP-830 microforge (Narishige, Tokyo, Japan) to a tip resistance of 0.8-1 MΩ when filled with pipette solution, pH 7.2, containing (in mM): 140 CsCl, 10 NaCl, 1 EGTA and 5 HEPES. During recordings the neurons were constantly perfused with a solution at pH 7.4, comprised of (in mM): 98 choline-Cl, 42 NaCl, 3 KCl, 2 CaCl2, 2 MgCl2, 10 HEPES, 10 glucose, 25 TEA and 3 4-AP.

Membrane currents were recorded using an Axopatch 200B amplifier, digitized with a Digidata 3200A interface (Axon Instruments, Foster City, CA.), and acquired at a frequency of 5 kHz using pClamp 9. Voltage dependence of activation was determined from peak currents in response to 50 ms test pulses ranging from -80 to +90 mV.

Whole-cell patch-clamp recordings were also carried out in CHO cells stably expressing the Nav1.3 α subunit. The same voltage protocol was conducted using micropipettes with a tip resistance of 2-4 MΩ filled with a solution at pH 7.2, containing (in mM): 105 Cs-Asp, 10 CsCl, 10 NaCl, 5 EGTA and 10 HEPES. During recordings the cells were constantly perfused with an external solution at pH 7.4 containing (in mM): 130 NaCl, 4 KCl, 1.5 CaCl2, 1 MgCl2, 10 HEPES and 5 glucose. For CHO cell recordings, compensation for leak current was carried out using the P/4 protocol included in the pClamp 9 acquisition software. For all recordings the membrane capacitance (Cm) and series resistance (Rs) were measured through the peak amplitude and decay constant of transients induced by repetitive depolarizing pulses of 10 mV.

Tissue collection and preparation

Adult male Sprague-Dawley rats (Charles River, Saint-Constant, Quebec, Canada) were euthanized by decapitation. Spinal cords with DRG attached were rapidly dissected, snap-frozen at -40°C in isopentane for 20 s and stored at -80°C. Frozen spinal cord tissue with DRGs attached were transversely cryosectioned at 14 μm and thaw-mounted onto Superfrost Plus slides (VWR, Montreal, Quebec, Canada). Slides were stored at -80°C until processing for in situ hybridization.

NaV1.3 riboprobe design and synthesis

A 409-base pair fragment spanning nt. 6325-6733 in the 3'-untranslated region of the rat Nav1.3 gene (accession number NM_013119) was amplified in PCR from rat genomic DNA using 5'-TATCCGTGTCAACTGGAC-3' as the forward primer and 5'-ACTTGTGGACTTAGCAAC-3' as the reverse primer. PCR cycling (reaction mix: 1 ng of genomic DNA, 0.2 μM of each dNTP, 1 mM of each primer, 5 U of Taq DNA polymerase in 1 × Taq DNA polymerase buffer) was 3 min at 95°C, followed by 25 cycles of 30 s at 95°C, 45 s at 50°C and 30 s at 72°C. The amplicon was isolated on an agarose gel using the QIAquick gel extraction kit (Qiagen, Mississauga, Ontario, Canada) and was ligated into pGEM-T-Easy vector (Promega, Nepean, Ontario, Canada). Plasmid from a single clone was purified using HiSpeed Plasmid Midi kit (Qiagen). The Nav1.3 plasmid was linearized using NcoI and SpeI restriction enzymes (Promega). Antisense riboprobes were transcribed in vitro using SP6 RNA polymerase (Promega) and radiolabeled with 35S-UTP and 35S-CTP (800 Ci/mmol; Amersham Biosciences, Inc). Following transcription, the Nav1.3 DNA template was digested with DNAse I (Promega) and subsequently purified using G-50 Sepharose microspin columns (GE Healthcare). The quality of labeled riboprobes was verified by polyacrylamide-urea gel electrophoresis and scintillation counting.

In situ hybridization (ISH) and histological analysis

ISH was performed on rat tissue sections as previously described (Ahmad et al 2007). Briefly, tissue sections were fixed with 4% paraformaldehyde, rinsed 3 times in 2 × standard sodium citrate buffer (2 × SSC), equilibrated in 0.1 M triethanolamine, and treated with 0.25% acetic anhydride in 0.1 M triethanolamine. After a rinse in 2 × SSC and dehydration through an ethanol series (50-100%), hybridization was performed in a buffer containing 75% formamide (Sigma), 600 mM NaCl, 10 mM Tris-HCl (pH 7.5), 1 mM EDTA, 1 × Denhardt's solution (Sigma), 50 μg/ml denatured salmon sperm DNA (Sigma), 10% dextran sulfate (Sigma), 20 mM dithiothreitol, and [35S]-labeled cRNA probe (20 × 106 cpm/ml) at 55°C overnight in chambers humidified with 75% formamide.

Following hybridization, slides were rinsed twice in 2 × SSC at room temperature, treated with 20 μg/ml RNase IA in RNase buffer (25 mM NaCl, 5 mM Tris-HCl pH 7.5, 0.5 mM EDTA pH 8.0) for 45 minutes at 37°C, and washed to a final stringency of 0.1 × SSC at 70°C. Sections were then dehydrated and exposed to Kodak Biomax MR-2 film. After exposed to film, the slides were dipped in Kodak NTB2 emulsion and exposed for 8 weeks at 4°C prior to development and counterstaining with hematoxylin and eosin.

Film autoradiograms were digitized with a high-resolution Xillix Microimager digital camera via the MCID image analysis system (Imaging Research, St-Catharines, Ontario, Canada). Bright- and darkfield photomicrographs of emulsion-dipped tissue sections were captured using a Leica (DMRBE/DM 4000B) microscope equipped with a Leica DFC490 digital camera. Digital images were transferred to Adobe Photoshop 7.0 for minimal image processing.

Statistical analysis

Data are presented as mean ± S.E.M. All statistical analyses for the difference in means were carried out using unpaired as well as paired Student's t test and one-way ANOVA followed by Bonferroni's multiple comparison tests. Normalized data were analyzed using nonparametric Mann-Whitney U test.

Results

Neuropathic vs Naïve Purinergic Response

The overall morphology of DRG neurons was indistinguishable between naïve and neuropathic conditions. Three distinct populations of neurons (small, medium and large diameter) were present in all cultures. For the purpose of this study, recordings were conducted only on small diameter DRG neurons nociceptors, based on cell body diameter of <30 μm, with functional P2X3 receptors as determined by rapidly activating and fast desensitizing current kinetics in response to the selective agonist α,β-meATP. In DRG neurons from both control and neuropathic animals, application of 10 μM α,β-meATP resulted in inward current (Figure 1A, B); however, in the neuropathic DRGs, α,β-meATP elicited a large transient spike, which was not observed in control DRGs. We hypothesized that this large inward spike in neuropathic neurons might be caused by activation of VGSCs. In other words, in neuropathic conditions, a small initial depolarization caused by the inward current through P2X receptors and not completely compensated by the clamp might be sufficient to trigger a regenerative inward sodium spike. To test this hypothesis, we applied a saturating concentration of TTX (1 μM) and found that it selectively inhibited the inward spike, leaving the purinergic ionotropic response at levels similar to naïve neurons (Figure 1C, D). These data suggest that after neuropathic injury, small diameter DRG neurons express large TTX-sensitive voltage-dependent sodium currents. It should be noted that we cannot be certain that the recorded purinergic currents are purely mediated by homomeric P2X3 receptors since it has been reported that neuropathic DRG neurons show increased expression of P2X2/3 heteromeric receptors [10], thus we will simply describe purinergic currents as P2X responses.
Figure 1

Hyperexcitability of neuropathic DRG neurons to P2X activation and reversal by TTX. Representative traces of P2X current responses induced by 10 μM α,β-meATP and recorded from cultured rat DRG neurons. (A) Recordings in control (naïve) neurons (B) in neuropathic SNL neurons, and (C) in neuropathic SNL neurons in the presence of 1 μM TTX. (D) Current densities of peak P2X responses from naïve and neuropathic DRG neurons, in absence and presence of 1 μM TTX (N = 6-17, *** p < 0.0005).

To examine more directly how P2X receptor activation influences the electroresponsiveness of neuropathic DRG neurons, we conducted current-clamp recordings under resting conditions with no current injection, then stimulated the DRG neurons with an application of 100 nM, 1 μM or 10 μM α,β-meATP. In naïve DRG neurons, α,β-meATP elicited dose-dependent cellular depolarizations. However, these responses were generally not sufficient to trigger neuronal firing (Figure 2A). None of the naïve neurons tested at 100 nM α,β-meATP generated action potentials, and 1 μM or 10 μM α,β-meATP applications induced action potentials in about 7% of naïve DRG neurons. In contrast, a greater proportion of neuropathic DRG neurons fired action potentials in response to P2X stimulation. For example, 100 nM α,β-meATP induced neuronal firing in about 29% of DRG neurons, 1 μM α,β-meATP induced 77% of neurons to fire, and all neuropathic neurons generated action potentials in response to 10 μM α,β-meATP (Figure 2B; N = 8-15 for each concentration in each group).
Figure 2

P2X activation triggers action potentials in neuropathic DRG neurons. (A) Representative traces obtained in current clamp recordings at resting membrane potential (no current injection), and action potentials induced by the application of increasing concentrations of α,β-meATP. (B) Percentage of naïve and neuropathic DRG neurons that generated action potentials in response to increasing concentrations of α,β-meATP. (N = 8-15, all cells were pooled).

Hyperexcitability of Neuropathic DRGs is Sensitive to PKC

To test the sensitivity of α,β-meATP-mediated current responses of both naïve and neuropathic DRG neurons to PKC modulation, we used the wide-spectrum protein kinase blocker staurosporine. In voltage clamp experiments, we found that the fast spike recorded in response to α,β-meATP in neuropathic neurons was inhibited by 500 nM staurosporine (Figure 3A). The current density of the response to 10 μM α,β-meATP was decreased by 76% (neuropathic: 115.41 ± 14.59 pA/pF; + staurosporine: 27.57 ± 7.42 pA/pF; N = 4-9; Figure 3A, B). Responses to α,β-meATP in naïve DRG neurons were not sensitive to staurosporine (Figure 3C, D), nor were the responses sensitive to pre-incubation with PKC activator PMA (data not shown). The α,β-meATP-evoked transient spike in neuropathic neurons was also significantly inhibited by calphostin C, a more selective inhibitor of PKC (Figure 3A, B; neuropathic: 115.14 ± 14.59 pA/pF; + calphostin C: 9.88 ± 2.07 pA/pF; N = 6-9).
Figure 3

Exaggerated α,β-meATP-evoked response after neuropathic injury is blunted by PKC inhibition. (A) Sample traces of current responses to 10 μM α,β-meATP in presence of PKC inhibitors staurosporine (500 nM) and calphostin C (100 nM) in neuropathic DRG neurons under voltage-clamp settings. (B) Current density of peak responses to 10 μM α,β-meATP in presence of PKC inhibitors (N = 4-17, ** p < 0.005 *** p < 0.0005, compared to the neuropathic group). (C) Representative traces of 10 μM α,β-meATP-evoked P2X3 responses in naïve DRG neurons (left), and after pre-incubation with 500 nM staurosporine (right). (D) Current density of 10 μM α,β-meATP-evoked P2X responses with and without 500 nM staurosporine (N = 5, non significant difference).

To ascertain how PKC affected the electroresponsiveness of naïve versus neuropathic DRG neurons to P2X receptor activation, we conducted current-clamp experiments to measure the effects of inhibiting PKC with 100 nM calphostin C on action potentials induced by 1 and 10 μM α,β-meATP. The difference in electroresponsiveness between naïve and neuropathic neurons was less robust when we stimulated them with 100 nM α,β-meATP, thus it was not included in this set of experiments. In neuropathic DRG neurons activated with 1 μM α,β-meATP, only 29% of the neurons fired action potentials when pre-exposed to calphostin C, compared to 77% in absence of the PKC blocker (Figure 4A, B). When the neurons were activated with 10 μM α,β-meATP, 86% of neuropathic DRG neurons pre-treated with calphostin C generated action potentials, compared to 100% of untreated neuropathic neurons (Figure 4A, B; N = 7-13 for each concentration in each group).
Figure 4

Inhibition of α,β-meATP-evoked action potentials by the PKC blocker calphostin C in neuropathic DRG neurons. (A) Typical recordings obtained from current-clamp experiments in neuropathic DRG neurons at resting membrane potential show action potentials generated in response to 1 and 10 μM α,β-meATP (upper panel), and their inhibition in the presence of 100 nM calphostin C (lower panel). (B) Percentage of DRG neurons that generated action potentials in response to α,β-meATP, in absence and presence of 100 nM calphostin C (N = 7-13).

Neuropathic Injury-Induced Changes in Function and Expression of Voltage-Gated Sodium Channels

To investigate the role of VGSCs in the hyperexcitable responses of neuropathic DRG neurons to α,β-meATP-evoked depolarization, we examined voltage-activated sodium currents in voltage-clamp experiments. We observed dramatically larger sodium current amplitudes in neuropathic VGSCs, compared to naïve controls, over a range of test potentials (Figure 5A). At the peak of the current-voltage relationship, the current density measured in neuropathic DRG neurons was 200% larger than in naïve neurons (Figure 5B). We also observed a significant leftward shift (-5 mV) in the voltage dependence of activation in neuropathic neurons (Figure 5C). Therefore both an increased current amplitude and a negative shift in voltage dependence of activation of VGSCs contribute to the hypersensitivity of neuropathic DRG neurons to purinergic stimulation.
Figure 5

Increased current amplitude and hyperpolarizing shift in voltage dependence of sensory sodium channels after neuropathic injury. (A) Representative current-voltage relationship traces of VGSC currents recorded from naïve and neuropathic DRG neurons. (B) Analysis of peak current amplitudes of voltage-gated sodium currents recorded at Vmax in naïve and neuropathic conditions (N = 4-5 for both groups, ** p < 0.005). (C) Sodium channel conductance was fitted with the Boltzman function (see Materials and Methods) from voltage-gated currents recorded in naïve and neuropathic neurons (N = 4-5).

To investigate expression changes in VGSC, we performed in situ hybridization (ISH) experiments to examine alterations of mRNA levels in DRG tissue following SNL injury. We probed the expression of the Nav1.3 gene based on reports that this VGSC subunit increases significantly after SNL injury (see discussion) and axotomy [12]. Nav1.3 mRNA expression was qualitatively assessed in DRG sections from naïve, sham-operated and SNL-injured adult rats. In both naïve and sham-operated rats, very weak Nav1.3 mRNA expression was detected over a subset of small-, medium- and large-diameter neurons as identified using light microscopy (data not shown). In contrast, unilateral ligation of L5 and L6 spinal nerves resulted in robust upregulation of Nav1.3 mRNA expression within the corresponding ipsilateral DRGs (Figure 6A, B). The increased level of Nav1.3 mRNA expression was detected as early as 2 days post-injury, and remained upregulated at all time points examined in small-, medium- and large-diameter neurons. No changes were detected in the intact L4 DRG, or in contralateral L5 and L6 DRGs from SNL injured rats.
Figure 6

Increased expression of Na v 1.3 mRNA in DRG neurons following SNL injury. (A) Autoradiographic in situ hybridization data showing increased levels of Nav1.3 mRNA in rat DRG neurons from 2 to 42 days after neuropathic injury. Arrows indicate the lumbar DRG level ipsilateral to the SNL injury. Note that the increase in Nav1.3 mRNA occurs in the ipsilateral (injured) L5 and L6 DRGs, but remains unchanged in (uninjured) L4 DRG and sham DRGs. Sham DRGs represent the 14 day post-injury time point. (B) High magnification (40×) images of emulsion-dipped sections showing increased Nav1.3 mRNA expression in cell bodies of small diameter DRG neurons (arrows) on the ipsilateral side of the nerve injury. Scale bar, 50 μm.

PKC Modulation of Nav1.3 Currents

As we did not observe any modulatory role of PKC on the function of endogenous P2X3 receptors in DRG neurons (Figure 3C, D), it is unlikely that PKC is modulating neuronal excitability by altering P2X3 function. A more likely mechanism for the effects of PKC on the excitability of neuropathic DRG neurons is a modulation of the activity of Nav1.3 channels. Because native DRG neurons express a wide range of VGSC subtypes, and since no pharmacological tools are available to isolate the Nav1.3 activity, we tested this hypothesis in voltage-clamp experiments on a CHO cell line stably expressing the Nav1.3 subunit [20]. These cells displayed robust and reproducible voltage-gated sodium currents (Figure 7A). After treatment with the PKC blocker calphostin C, the voltage-dependence of Nav1.3 activity was shifted by 10 mV in the depolarizing direction (Figure 7B). PKC inhibition also significantly reduced the amplitude of Nav1.3 currents (Figure 7C). The current density at peak activation was reduced by 46% by calphostin C (control: 335.46 ± 79.41 pA/pF; + calphostin C: 179.70 ± 23.53 pA/pF; N = 6-8).
Figure 7

Na v 1.3 activity is positively regulated by PKC. (A) Membrane potential depolarization induced Nav1.3-mediated sodium currents in Nav1.3-transfected CHO cells evoked using stimulus protocol described in methods section. (B) Current-voltage relationship of Nav1.3 activity in the presence and absence of 100 nM calphostin C (N = 6-8). (C) Voltage-dependent current density mediated by Nav1.3 channels in CHO cells in the presence and absence of 100 nM calphostin C (N = 6-8).

Discussion

The present study suggests that activation of P2X receptors elicits excessive firing in neuropathic DRG neurons indirectly, through activation of upregulated Nav1.3 sodium channels. We also show that VGSC-mediated hyperexcitability is modulated by PKC.

Activation of P2X Receptors Elicits Ectopic Action Potentials

Neuropathic injury models such as SNL induce a wide array of changes in the physiology of DRG neurons. Although SNL neurons display excessive firing of action potentials in response to P2X activation, we cannot conclude that the ability to trigger hypersensitive responses is exclusive to P2X receptors. Indeed, we also observed similar abnormal action potential firing in a small number of neuropathic cells stimulated with the TRPV1 agonist capsaicin (data not shown). We did not observe any significant changes in the current amplitude of P2X receptors in neuropathic DRG neurons treated with a saturating concentration of TTX. This is in accordance to another study of P2X receptor activity in injured sensory neurons, where it was reported that the amplitude of α,β-meATP-evoked currents in neuropathic small diameter DRG neurons did not significantly differ from those recorded from naïve neurons [10]. These observations are consistent with the idea that neuropathic neurons are generally hyper-responsive to depolarizing stimuli because of their intrinsic, voltage-dependent hyperexcitability. P2X3 receptors are fast-desensitizing while other receptor-channels such as TRPV1 have slower kinetics of activation and desensitization [21]. Thus, ligand-gated cation channels with different kinetics may elicit specific patterns and/or durations of ectopic action potential firing.

PKC Modulation of Neuronal Hyperexcitability

The involvement of PKC in neuropathic pain has been well demonstrated [22], and certain isoforms of PKC are high value targets for pain therapeutics [23]. However, the mechanism by which PKC regulates neuronal excitability remains elusive. The function of several sensory receptor-channels has been shown to be modulated by PKC, such as TRPV1 [24], P2X2/3 [25], and ASICs [26]. In agreement with reports demonstrating the role of protein kinases in neuropathic pain mechanisms [17, 27, 28], we show that sensitization to ATP of neuropathic neurons can be inhibited by the wide-spectrum protein kinase blocker staurosporine, as well as calphostin C, a more selective PKC inhibitor [29] shown to be effective against PKC isoforms involved in neuropathic pain [30].

We did not observe any effect of staurosporine or the PKC activator PMA on P2X3 responses to α,β-meATP in either naïve DRG neurons or HEK293 cells expressing homomeric P2X3 receptors (data not shown), which strongly suggests that PKC is not contributing to hyperexcitability through a direct modulation of P2X receptors in neuropathic DRG neurons. Our voltage-clamp recordings conducted in the presence of PKC inhibitors showed a decrease in the fast spike component of the inward current, corresponding to a reduction in voltage-gated sodium current, while the remaining P2X component was relatively unchanged. The modulation of sodium channel activity by calphostin C was also observed in our current-clamp experiments where we demonstrated that PKC inhibition attenuates the generation of action potentials in neuropathic neurons. In line with evidence demonstrating modulation of VGSCs by PKC [1416, 3133], our results point to a major role for PKC-modulated VGSCs in the hypersensitivity of neuropathic DRG neurons to purinergic stimulation.

Upregulation of Nav1.3 Sodium Channels Expression and Activity

In order to verify that PKC is regulating hyperexcitability through modulation of VGSC, we first needed to identify which VGSC α subunit is up-regulated in neuropathic DRG neurons. From our characterization of the changes to the VGSC profile following SNL, the increase in current amplitude and the hyperpolarizing shift in voltage-dependence observed in neuropathic neurons are likely caused by increased expression of Nav1.3. This is consistent with reports showing an increase in the expression of embryonic Nav1.3 α subunit expression in DRG neurons after axotomy [12] and SNL injury [34, 35]. We cannot exclude possible changes in the function of other VGSC subunits, such as Nav1.7 and Nav1.8, which may contribute to neuropathic hyperexcitability; however, their expression levels have been shown to decrease after neuropathic injury [36, 37]. Under normal conditions, Nav1.8 is the main generator of action potentials in small diameter DRG neurons. With respect to activation, Nav1.8 has a V0.5 of -16 to -21 mV, whereas for Nav1.3 the V0.5 is -23 mV [38]. The difference in voltage-dependence of the two Nav subunits corresponds to the difference in voltage-dependence that we observed between neuropathic and naïve DRG neurons, suggesting that Nav1.3 is a major contributor to the VGSC-mediated currents in neuropathic neurons.

Increased expression of the Nav1.3 α subunit following SNL injury was confirmed through our ISH data. The increased expression level was confined to the injured L5 and L6 DRGs and remained unaltered on the contralateral (uninjured) DRGs. Changes in expression of VGSC subunit mRNA have been reported in both rodents and humans [12, 34, 37]. An increase in expression of Nav1.3 has been observed in trigeminal neuralgia patients [37], suggesting a role for Nav1.3 modulation in pathological pain. Neuronal VGSCs are heteromeric complexes containing α subunits associated with β subunits. These auxiliary subunits have been shown to modulate the function of various α subunits [39]. Of the three β subunits identified so far, the most relevant here is the β3 subunit because of its co-localization with Nav1.3 in small diameter DRG neurons. Furthermore, the expression of both proteins increases after neuropathic injury within the same population of neurons [12, 40]. However, the modulatory effects of the β3 subunit on the Nav1.3 subunit are not clear. Some have reported a depolarizing shift in the voltage-dependence of activation and inactivation of Nav1.3 [41, 42], others reported no change in voltage-dependence of activation, but did observe a decrease in the rate of recovery from inactivation [20]. Unlike other α subunits, the current density of Nav1.3 does not seem to be affected by the presence of β subunits [20, 40]. In any case, the potential modulation of Nav1.3 by the auxiliary β3 subunit does not fit with the changes in the function of Nav1.3 after neuropathic injury that we are reporting here. However, because all these studies were based on the use of transfected cell lines, the exact role of native β3 subunits in sensory neurons is still unknown so they could possibly facilitate neuronal hyperexcitability. While some observed that treatment with antisense oligodeoxynucleotides targeting Nav1.3 reversed changes in pain responses associated with nerve injury [43, 44], others reported that decreasing expression of Nav1.3 was not sufficient to attenuate neuropathic pain behaviours [45, 46]. There is currently no consensus on the involvement of Nav1.3 function in mediating neuropathic pain. Therefore, until a selective blocker is available for clinical evaluation, its contribution to pain pathology will remain unclear.

PKC Regulates Nav1.3 Activity

After identifying Nav1.3 as the VGSC α subunit predominantly responsible for the hyperexcitability following neuropathic injury, we examined the PKC modulation of its function isolated in a heterologous system. From currents recorded from CHO- Nav1.3 cells, it was clear that PKC enhances the function of Nav1.3 by increasing its activity at more hyperpolarizing potentials and by increasing its current amplitude, a combination that could dramatically boost the sensitivity of DRG nociceptors to a range of depolarizing stimuli. Several VGSC isoforms have been shown to be modulated by PKC [15, 16, 32], but we report here for the first time the positive regulation of Nav1.3 function by PKC in native as well as recombinant cell preparations. The molecular mechanisms of this modulation require further investigation to know if Nav1.3 is directly phosphorylated by PKC such as the Nav1.8 subunit [47]. In any case, the identification of phosphorylated domain(s) in the Nav1.3 subunit or associated proteins could provide valuable information for the design of novel neuropathic pain therapeutics.

Conclusions

The present study shows that injury-induced hyper-responsiveness of DRG neurons to P2X activation is mediated by increased expression of Nav1.3 sodium channel subunit, and not due to any significant change in the function of P2X receptors. We also provide evidence for the first time that Nav1.3-mediated hyperexcitability can be modulated by PKC, which directly regulates the activity of Nav1.3 channels. This study emphasizes the importance of VGSCs in injury-induced increases in excitability to algogenic mediators, and provides new insights into functional regulation of Nav1.3 in injured peripheral neurons.

Declarations

Acknowledgements

This work has been supported by operating grants from CIHR (PS) and AstraZeneca R&D Montreal (CQC and DO). GM holds a graduate studentship from NSERC-FQRNT/IIS (AstraZeneca R&D Montreal).

Authors’ Affiliations

(1)
Montreal Neurological Institute and The Alan Edwards Centre for Research on Pain, Department of Neurology & Neurosurgery, McGill University
(2)
Department of Bioscience, AstraZeneca R&D Montreal

References

  1. Dowd E, McQueen DS, Chessell IP, Humphrey PP: P2X receptor-mediated excitation of nociceptive afferents in the normal and arthritic rat knee joint. Br J Pharmacol 1998, 125: 341–346. 10.1038/sj.bjp.0702080PubMed CentralPubMedView ArticleGoogle Scholar
  2. Rong W, Burnstock G, Spyer KM: P2X purinoceptor-mediated excitation of trigeminal lingual nerve terminals in an in vitro intra-arterially perfused rat tongue preparation. J Physiol 2000,524(Pt 3):891–902. 10.1111/j.1469-7793.2000.00891.xPubMed CentralPubMedView ArticleGoogle Scholar
  3. Barclay J, Patel S, Dorn G, Wotherspoon G, Moffatt S, Eunson L, Abdel'al S, Natt F, Hall J, Winter J, et al.: Functional downregulation of P2X3 receptor subunit in rat sensory neurons reveals a significant role in chronic neuropathic and inflammatory pain. J Neurosci 2002, 22: 8139–8147.PubMedGoogle Scholar
  4. Burnstock G, Wood JN: Purinergic receptors: their role in nociception and primary afferent neurotransmission. Curr Opin Neurobiol 1996, 6: 526–532. 10.1016/S0959-4388(96)80060-2PubMedView ArticleGoogle Scholar
  5. Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y, Novakovic S, Malmberg AB, Cain G, Berson A, Kassotakis L, et al.: Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 2000, 407: 1011–1015. 10.1038/35039519PubMedView ArticleGoogle Scholar
  6. North RA, Verkhratsky A: Purinergic transmission in the central nervous system. Pflugers Arch 2006, 452: 479–485. 10.1007/s00424-006-0060-yPubMedView ArticleGoogle Scholar
  7. Novakovic SD, Kassotakis LC, Oglesby IB, Smith JA, Eglen RM, Ford AP, Hunter JC: Immunocytochemical localization of P2X3 purinoceptors in sensory neurons in naive rats and following neuropathic injury. Pain 1999, 80: 273–282. 10.1016/S0304-3959(98)00225-5PubMedView ArticleGoogle Scholar
  8. Xiang Z, Xiong Y, Yan N, Li X, Mao Y, Ni X, He C, LaMotte RH, Burnstock G, Sun J: Functional up-regulation of P2X 3 receptors in the chronically compressed dorsal root ganglion. Pain 2008, 140: 23–34. 10.1016/j.pain.2008.07.006PubMed CentralPubMedView ArticleGoogle Scholar
  9. Bradbury EJ, Burnstock G, McMahon SB: The expression of P2X3 purinoreceptors in sensory neurons: effects of axotomy and glial-derived neurotrophic factor. Mol Cell Neurosci 1998, 12: 256–268. 10.1006/mcne.1998.0719PubMedView ArticleGoogle Scholar
  10. Kage K, Niforatos W, Zhu CZ, Lynch KJ, Honore P, Jarvis MF: Alteration of dorsal root ganglion P2X3 receptor expression and function following spinal nerve ligation in the rat. Exp Brain Res 2002, 147: 511–519. 10.1007/s00221-002-1263-xPubMedView ArticleGoogle Scholar
  11. Devor M: Sodium channels and mechanisms of neuropathic pain. J Pain 2006, 7: S3-S12. 10.1016/j.jpain.2005.09.006PubMedView ArticleGoogle Scholar
  12. Waxman SG, Kocsis JD, Black JA: Type III sodium channel mRNA is expressed in embryonic but not adult spinal sensory neurons, and is reexpressed following axotomy. J Neurophysiol 1994, 72: 466–470.PubMed CentralPubMedGoogle Scholar
  13. Felts PA, Yokoyama S, Dib-Hajj S, Black JA, Waxman SG: Sodium channel alpha-subunit mRNAs I, II, III, NaG, Na6 and hNE (PN1): different expression patterns in developing rat nervous system. Brain Res Mol Brain Res 1997, 45: 71–82. 10.1016/S0169-328X(96)00241-0PubMedView ArticleGoogle Scholar
  14. Chen Y, Yu FH, Surmeier DJ, Scheuer T, Catterall WA: Neuromodulation of Na+ channel slow inactivation via cAMP-dependent protein kinase and protein kinase C. Neuron 2006, 49: 409–420. 10.1016/j.neuron.2006.01.009PubMedView ArticleGoogle Scholar
  15. Baker MD: Protein kinase C mediates up-regulation of tetrodotoxin-resistant, persistent Na+ current in rat and mouse sensory neurones. J Physiol 2005, 567: 851–867. 10.1113/jphysiol.2005.089771PubMed CentralPubMedView ArticleGoogle Scholar
  16. Vijayaragavan K, Boutjdir M, Chahine M: Modulation of Na v 1.7 and Na v 1.8 peripheral nerve sodium channels by protein kinase A and protein kinase C. J Neurophysiol 2004, 91: 1556–1569. 10.1152/jn.00676.2003PubMedView ArticleGoogle Scholar
  17. Cesare P, Dekker LV, Sardini A, Parker PJ, McNaughton PA: Specific involvement of PKC-epsilon in sensitization of the neuronal response to painful heat. Neuron 1999, 23: 617–624. 10.1016/S0896-6273(00)80813-2PubMedView ArticleGoogle Scholar
  18. Malmberg AB, Chen C, Tonegawa S, Basbaum AI: Preserved acute pain and reduced neuropathic pain in mice lacking PKCgamma. Science 1997, 278: 279–283. 10.1126/science.278.5336.279PubMedView ArticleGoogle Scholar
  19. Kim SH, Chung JM: An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992, 50: 355–363. 10.1016/0304-3959(92)90041-9PubMedView ArticleGoogle Scholar
  20. Meadows LS, Chen YH, Powell AJ, Clare JJ, Ragsdale DS: Functional modulation of human brain Na v 1.3 sodium channels, expressed in mammalian cells, by auxiliary beta 1, beta 2 and beta 3 subunits. Neuroscience 2002, 114: 745–753. 10.1016/S0306-4522(02)00242-7PubMedView ArticleGoogle Scholar
  21. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D: The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389: 816–824. 10.1038/39807PubMedView ArticleGoogle Scholar
  22. Velazquez KT, Mohammad H, Sweitzer SM: Protein kinase C in pain: involvement of multiple isoforms. Pharmacol Res 2007, 55: 578–589. 10.1016/j.phrs.2007.04.006PubMed CentralPubMedView ArticleGoogle Scholar
  23. Yonezawa T, Kurata R, Kimura M, Inoko H: PKC delta and epsilon in drug targeting and therapeutics. Recent Pat DNA Gene Seq 2009, 3: 96–101. 10.2174/187221509788654205PubMedView ArticleGoogle Scholar
  24. Plant TD, Zollner C, Kepura F, Mousa SS, Eichhorst J, Schaefer M, Furkert J, Stein C, Oksche A: Endothelin potentiates TRPV1 via ETA receptor-mediated activation of protein kinase C. Mol Pain 2007, 3: 35. 10.1186/1744-8069-3-35PubMed CentralPubMedView ArticleGoogle Scholar
  25. Maruo K, Yamamoto H, Yamamoto S, Nagata T, Fujikawa H, Kanno T, Yaguchi T, Maruo S, Yoshiya S, Nishizaki T: Modulation of P2X receptors via adrenergic pathways in rat dorsal root ganglion neurons after sciatic nerve injury. Pain 2006, 120: 106–112. 10.1016/j.pain.2005.10.016PubMedView ArticleGoogle Scholar
  26. Baron A, Deval E, Salinas M, Lingueglia E, Voilley N, Lazdunski M: Protein kinase C stimulates the acid-sensing ion channel ASIC2a via the PDZ domain-containing protein PICK1. J Biol Chem 2002, 277: 50463–50468. 10.1074/jbc.M208848200PubMedView ArticleGoogle Scholar
  27. Dina OA, Barletta J, Chen X, Mutero A, Martin A, Messing RO, Levine JD: Key role for the epsilon isoform of protein kinase C in painful alcoholic neuropathy in the rat. J Neurosci 2000, 20: 8614–8619.PubMedGoogle Scholar
  28. Hua XY, Chen P, Yaksh TL: Inhibition of spinal protein kinase C reduces nerve injury-induced tactile allodynia in neuropathic rats. Neurosci Lett 1999, 276: 99–102. 10.1016/S0304-3940(99)00818-6PubMedView ArticleGoogle Scholar
  29. Kobayashi E, Nakano H, Morimoto M, Tamaoki T: Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1989, 159: 548–553. 10.1016/0006-291X(89)90028-4PubMedView ArticleGoogle Scholar
  30. Norcini M, Vivoli E, Galeotti N, Bianchi E, Bartolini A, Ghelardini C: Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat. Pain 2009, 146: 141–147. 10.1016/j.pain.2009.07.017PubMedView ArticleGoogle Scholar
  31. Curia G, Aracri P, Colombo E, Scalmani P, Mantegazza M, Avanzini G, Franceschetti S: Phosphorylation of sodium channels mediated by protein kinase-C modulates inhibition by topiramate of tetrodotoxin-sensitive transient sodium current. Br J Pharmacol 2007, 150: 792–797. 10.1038/sj.bjp.0707144PubMed CentralPubMedView ArticleGoogle Scholar
  32. Gold MS, Levine JD, Correa AM: Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro. J Neurosci 1998, 18: 10345–10355.PubMedGoogle Scholar
  33. Wada A, Yanagita T, Yokoo H, Kobayashi H: Regulation of cell surface expression of voltage-dependent Na v 1.7 sodium channels: mRNA stability and posttranscriptional control in adrenal chromaffin cells. Front Biosci 2004, 9: 1954–1966. 10.2741/1314PubMedView ArticleGoogle Scholar
  34. Fukuoka T, Kobayashi K, Yamanaka H, Obata K, Dai Y, Noguchi K: Comparative study of the distribution of the alpha-subunits of voltage-gated sodium channels in normal and axotomized rat dorsal root ganglion neurons. J Comp Neurol 2008, 510: 188–206. 10.1002/cne.21786PubMedView ArticleGoogle Scholar
  35. Kim CH, Oh Y, Chung JM, Chung K: The changes in expression of three subtypes of TTX sensitive sodium channels in sensory neurons after spinal nerve ligation. Brain Res Mol Brain Res 2001, 95: 153–161. 10.1016/S0169-328X(01)00226-1PubMedView ArticleGoogle Scholar
  36. Boucher TJ, Okuse K, Bennett DL, Munson JB, Wood JN, McMahon SB: Potent analgesic effects of GDNF in neuropathic pain states. Science 2000, 290: 124–127. 10.1126/science.290.5489.124PubMedView ArticleGoogle Scholar
  37. Siqueira SR, Alves B, Malpartida HM, Teixeira MJ, Siqueira JT: Abnormal expression of voltage-gated sodium channels Na v 1.7, Na v 1.3 and Na v 1.8 in trigeminal neuralgia. Neuroscience 2009, 164: 573–577. 10.1016/j.neuroscience.2009.08.037PubMedView ArticleGoogle Scholar
  38. Catterall WA, Goldin AL, Waxman SG: International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 2005, 57: 397–409. 10.1124/pr.57.4.4PubMedView ArticleGoogle Scholar
  39. Isom LL, De Jongh KS, Patton DE, Reber BF, Offord J, Charbonneau H, Walsh K, Goldin AL, Catterall WA: Primary structure and functional expression of the beta 1 subunit of the rat brain sodium channel. Science 1992, 256: 839–842. 10.1126/science.1375395PubMedView ArticleGoogle Scholar
  40. Shah BS, Stevens EB, Gonzalez MI, Bramwell S, Pinnock RD, Lee K, Dixon AK: beta3, a novel auxiliary subunit for the voltage-gated sodium channel, is expressed preferentially in sensory neurons and is upregulated in the chronic constriction injury model of neuropathic pain. Eur J Neurosci 2000, 12: 3985–3990. 10.1046/j.1460-9568.2000.00294.xPubMedView ArticleGoogle Scholar
  41. Cummins TR, Aglieco F, Renganathan M, Herzog RI, Dib-Hajj SD, Waxman SG: Na v 1.3 sodium channels: rapid repriming and slow closed-state inactivation display quantitative differences after expression in a mammalian cell line and in spinal sensory neurons. J Neurosci 2001, 21: 5952–5961.PubMedGoogle Scholar
  42. Cusdin FS, Nietlispach D, Maman J, Dale TJ, Powell AJ, Clare JJ, Jackson AP: The sodium channel {beta}3-subunit induces multiphasic gating in Na V 1.3 and affects fast inactivation via distinct intracellular regions. J Biol Chem 2010, 285: 33404–33412. 10.1074/jbc.M110.114058PubMed CentralPubMedView ArticleGoogle Scholar
  43. Hains BC, Klein JP, Saab CY, Craner MJ, Black JA, Waxman SG: Upregulation of sodium channel Na v 1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury. J Neurosci 2003, 23: 8881–8892.PubMedGoogle Scholar
  44. Hains BC, Saab CY, Klein JP, Craner MJ, Waxman SG: Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury. J Neurosci 2004, 24: 4832–4839. 10.1523/JNEUROSCI.0300-04.2004PubMedView ArticleGoogle Scholar
  45. Lindia JA, Kohler MG, Martin WJ, Abbadie C: Relationship between sodium channel Na v 1.3 expression and neuropathic pain behavior in rats. Pain 2005, 117: 145–153. 10.1016/j.pain.2005.05.027PubMedView ArticleGoogle Scholar
  46. Nassar MA, Baker MD, Levato A, Ingram R, Mallucci G, McMahon SB, Wood JN: Nerve injury induces robust allodynia and ectopic discharges in Na v 1.3 null mutant mice. Mol Pain 2006, 2: 33. 10.1186/1744-8069-2-33PubMed CentralPubMedView ArticleGoogle Scholar
  47. Hudmon A, Choi JS, Tyrrell L, Black JA, Rush AM, Waxman SG, Dib-Hajj SD: Phosphorylation of sodium channel Na v 1.8 by p38 mitogen-activated protein kinase increases current density in dorsal root ganglion neurons. J Neurosci 2008, 28: 3190–3201. 10.1523/JNEUROSCI.4403-07.2008PubMedView ArticleGoogle Scholar

Copyright

© Mo et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement